? Purified Amniotic Fluid Therapy

Harnessing Birth Tissue for Natural Healing and Regeneration

What Is Purified Amniotic Fluid?

Purified amniotic fluid (PAF) is a cell-free biologic derived from the protective fluid surrounding a baby during pregnancy. This fluid is ethically collected during planned C-sections from full-term healthy births and processed to remove all cells, leaving behind a potent mix of natural healing compounds, including:

  • Growth factors
  • Anti-inflammatory cytokines
  • Hyaluronic acid
  • Extracellular vesicles
  • Proteins that signal tissue repair¹

These components work together to promote healing, reduce inflammation, and support tissue regeneration—without containing live stem cells.

Why We Use Purified Amniotic Fluid

At Johnson Medical Center, we utilize PAF for patients who may benefit from its rich array of natural healing compounds. It offers a potent anti-inflammatory effect and stimulates the body’s innate healing processes.

PAF is:

  • Non-surgical and minimally invasive
  • Compatible with the body (low risk of rejection)
  • Free of live cells, simplifying regulation and administration²

Conditions Treated

Purified Amniotic Fluid Therapy has been applied to:

Orthopedic and Soft Tissue Conditions

  • Knee, hip, and shoulder arthritis
  • Spine-related joint pain
  • Degenerative disc disease
  • Chronic tendon injuries
  • Post-operative inflammation
  • Soft tissue pain unresponsive to other treatments

Wound Care Applications

  • Burns
  • Diabetic foot ulcers
  • Venous leg ulcers³

Systemic Conditions

Emerging research suggests potential benefits for systemic inflammatory conditions and immune modulation, though further studies are needed to fully understand these applications¹.

We recommend this therapy when the primary goals are to reduce inflammation and stimulate natural healing, especially in patients with conditions that have not responded to conventional treatments.

How It Works

  1. Evaluation: We assess your condition to determine if PAF is the appropriate therapy.
  2. Injection: The purified fluid is injected into the affected area using ultrasound guidance for precision.
  3. Response: Over the following weeks, patients often experience decreased pain, increased mobility, and improved function.

Safety and Quality

The amniotic fluid is collected from consenting mothers during planned C-sections at full-term delivery. It is processed in FDA-registered, cGMP-compliant laboratories to ensure sterility and safety. Since the product is acellular, the risk of immune reaction is extremely low².

A Natural Path to Healing

Purified Amniotic Fluid Therapy offers a natural alternative to steroids and surgery. While it does not contain stem cells, it provides a rich array of growth factors and proteins that support the body’s healing processes.

? Sources
  1. https://pmc.ncbi.nlm.nih.gov/articles/PMC9687956/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC7880092/
  3. https://www.jwmr.org/journal/view.php?number=437/

Regulatory Information

Johnson Medical Center is fully committed to complying with all Florida state and FDA regulations. Our MSC therapies are offered under approved protocols to ensure patient safety and regulatory adherence.

Before treatment, our patients receive detailed information about the investigational nature of MSC therapies, including potential risks and benefits, as required by Florida law. We are committed to ensuring you make an informed decision about your care.

Our umbilical cord-derived MSC therapies are processed in facilities that comply with FDA’s current Good Manufacturing Practices (cGMP) and Florida state regulations, ensuring the highest standards of safety and quality.

The mesenchymal signaling cell (MSC) therapies offered at Johnson Medical Center are investigational and not currently approved by the U.S. Food and Drug Administration (FDA) for the treatment of arthritic joint conditions or soft tissue injuries. These therapies are provided under an FDA-approved clinical trial or expanded access program. Patients should be aware that experimental treatments carry risks, including infection or lack of efficacy, and should discuss these with their healthcare provider. To report any adverse events, please contact the FDA’s MedWatch program at www.fda.gov/medwatch or 1-800-FDA-0178.

In compliance with Florida law, Johnson Medical Center informs patients that our mesenchymal signaling cell (MSC) therapies are not approved by the FDA for the treatment of arthritic joint conditions or soft tissue injuries. Our clinic is registered with the Florida Department of Health, lab adheres to FDA manufacturing standards, and undergoes annual state inspections. During the informed consent process, we provide detailed information about the investigational nature of these therapies, including potential risks and benefits.